Latest Updates of Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com
Page 6 - Global Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Phase Today - Breaking & Trending Today
BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia
European Commission Approval Decision Expected Q4 2023 Opinion Based on Positive Results from Global Phase 2 and Ongoing Extension Study U.S. Food and Drug Administration PDUFA Target Action Date...
Source: marketscreener.com
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update - Connect Biopharma Hldgs (NASDAQ:CNTB)
Key data readouts with Company's lead drug candidate rademikibart expected in the fourth quarter of 2023 Topline results from Stage 2 of the China pivotal trial in atopic dermatitisTopline results from Global Phase 2
Source: benzinga.com
FRESCO-2: A Global Phase 3 Multiregional Clinical Trial Evaluating the Efficacy and Safety of Fruquintinib in Patients With Refractory Metastatic Colorectal Cancer
Arvind Dasari, MD, MS, presents data from the FRESCO-2 clinical trial evaluating fruquintinib in patients with refractory metastatic colorectal cancer, and provides insights on the clinical implications of the results.
Source: onclive.com
Kintor Pharmaceutical : Pharma Announces 2023 Interim Results and Recent Business Highlights -Today at 09:01 am
Suzhou, August 28, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced its 2023...
Source: marketscreener.com